awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38743281-11A5A6E6-B4A3-4894-8673-D6E536CA86D9
Q38743281-11A5A6E6-B4A3-4894-8673-D6E536CA86D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38743281-11A5A6E6-B4A3-4894-8673-D6E536CA86D9
Brivaracetam: First Global Approval.
P2860
Q38743281-11A5A6E6-B4A3-4894-8673-D6E536CA86D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38743281-11A5A6E6-B4A3-4894-8673-D6E536CA86D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c1726a46188ee84019042f408ecc6698983cb3a
P2860
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.